+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Obsessive Compulsive Disorder Drug"

From
Obsessive Compulsive Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Obsessive Compulsive Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Obsessive-compulsive Disorder Drugs Market 2025-2029 - Product Thumbnail Image

Obsessive-compulsive Disorder Drugs Market 2025-2029

  • Report
  • March 2025
  • 217 Pages
  • Global
From
Depression Drugs Market 2025-2033 - Product Thumbnail Image

Depression Drugs Market 2025-2033

  • Report
  • March 2025
  • 148 Pages
  • Global
From
Antidepressants Drugs Market 2024-2028 - Product Thumbnail Image

Antidepressants Drugs Market 2024-2028

  • Report
  • July 2024
  • 138 Pages
  • Global
From
From
From
From
  • 20 Results (Page 1 of 1)
Loading Indicator

Obsessive Compulsive Disorder (OCD) is a mental disorder characterized by intrusive thoughts that produce anxiety, and by repetitive behaviors aimed at reducing that anxiety. OCD is treated with a combination of psychotherapy and medication. Drugs used to treat OCD include selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and monoamine oxidase inhibitors (MAOIs). SSRIs are the most commonly prescribed medications for OCD, as they are generally well-tolerated and have fewer side effects than other medications. The OCD drug market is highly competitive, with a number of major pharmaceutical companies offering products. These include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Novartis. Other companies, such as Lundbeck, Otsuka, and Sunovion, also offer products for the treatment of OCD. Show Less Read more